多发性硬化症中的疼痛:临床表型和治疗策略 - - 叙述性综述
Livia Sophie Lang1, Maria Protopapa1, Stefan Bittner1
1Department of Neurology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Pain reports
|February 20, 2026
概括
疼痛显著影响多发性硬化症 (MS) 患者,影响高达86%. 基于机制的方法和多模式治疗对于有效管理MS疼痛至关重要.
科学领域:
- 神经学 神经学
- 疼痛医学 医学 疼痛医学
- 临床管理 临床管理
背景情况:
- 疼痛是多发性硬化症 (MS) 的普遍和衰弱症状,经常被诊断不足和治疗不足.
- 在患有多发性硬化症的人中,患病率在29%至86%之间,很大一部分人认为这是他们最痛苦的症状.
研究的目的:
- 审查有关MS相关疼痛的流行,机制,临床表现和治疗策略的当前知识.
- 强调这些知识对有效的临床管理的影响.
主要方法:
- 进行了叙事文学评论.
- 综合了有关MS疼痛的流行病学,临床和机械学证据.
主要成果:
- 多发性硬化症的疼痛包括感觉性,神经病变性,鼻膜性或混合类型,表现为头痛,三角神经疼痛,疼痛的性等.
- 药物治疗对特定疼痛亚型的证据有限,而结构化炼在非药物治疗策略中显示出一致的益处.
- 解决疲劳,抑郁和睡眠障碍的多模式方法是最有效的.
结论:
- 疼痛是所有多发性硬化症表型中常见和致残的问题,但在临床实践中往往管理不当.
- 以基于机制的分类为指导的个性化,多模式的治疗策略,提供了最有前途的途径,以提高患者的治疗结果.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Analgesia and Pain Management
3.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Multiple Sclerosis l: Introduction
31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31


